AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T)
Authors: WALKER RE CARTER CS MUUL L NATARAJAN V HERPIN BR LEITMAN SF KLEIN HG MULLEN CA METCALF JA BASELER M FALLOON J DAVEY RT KOVACS JA POLIS MA MASUR H BLAESE RM LANE HC
Citation: Re. Walker et al., PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T), Nature medicine, 4(7), 1998, pp. 852-856
ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: PISCITELLI SC VOGEL S FIGG WD RAJE S FORREST A METCALF JA BASELER M FALLOON J
Citation: Sc. Piscitelli et al., ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Pharmacotherapy, 18(6), 1998, pp. 1212-1216
VISCERAL ABDOMINAL-FAT ACCUMULATION ASSOCIATED WITH USE OF INDINAVIR
Authors: MILLER KD JONES E YANOVSKI JA SHANKAR R FEUERSTEIN I FALLOON J
Citation: Kd. Miller et al., VISCERAL ABDOMINAL-FAT ACCUMULATION ASSOCIATED WITH USE OF INDINAVIR, Lancet, 351(9106), 1998, pp. 871-875
PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE IS ASSOCIATED WITH INCREASING DISRUPTIONS WITHIN THE CD4(-CELL RECEPTOR REPERTOIRE() T)
Authors: GEABANACLOCHE JC WEISKOPF EE HALLAHAN C DEQUIROS JCLB FLANIGAN M MICAN JM FALLOON J BASELER M STEVENS R LANE HC CONNORS M
Citation: Jc. Geabanacloche et al., PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE IS ASSOCIATED WITH INCREASING DISRUPTIONS WITHIN THE CD4(-CELL RECEPTOR REPERTOIRE() T), The Journal of infectious diseases, 177(3), 1998, pp. 579-585
INDINAVIR AND INTERSTITIAL NEPHRITIS - IN RESPONSE
Authors: KOPP JB MILLER KD FALLOON J
Citation: Jb. Kopp et al., INDINAVIR AND INTERSTITIAL NEPHRITIS - IN RESPONSE, Annals of internal medicine, 128(4), 1998, pp. 320-321
HIV-INFECTION INDUCES CHANGES IN CD4(-CELL PHENOTYPE AND DEPLETIONS WITHIN THE CD4(+) T-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES() T)
Authors: CONNORS M KOVACS JA KREVAT S GEABANACLOCHE JC SNELLER MC FLANIGAN M METCALF JA WALKER RE FALLOON J BASELER M STEVENS R FEUERSTEIN I MASUR H LANE HC
Citation: M. Connors et al., HIV-INFECTION INDUCES CHANGES IN CD4(-CELL PHENOTYPE AND DEPLETIONS WITHIN THE CD4(+) T-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES() T), Nature medicine, 3(5), 1997, pp. 533-540
SYMPTOMATIC APPENDICEAL WALL THICKENING IN AN HIV-INFECTED PATIENT CAUSED BY INTERLEUKIN-2 THERAPY
Authors: AVILA NA DWYER AJ FALLOON J
Citation: Na. Avila et al., SYMPTOMATIC APPENDICEAL WALL THICKENING IN AN HIV-INFECTED PATIENT CAUSED BY INTERLEUKIN-2 THERAPY, American journal of roentgenology, 169(2), 1997, pp. 499-500
HIV-INFECTION INDUCES PROGRESSIVE DEPLETIONS WITHIN THE CD4-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES( T)
Authors: GEABANACLOCHE JC WEISKOPF E LOPEZ JC FALLOON J BASELER M STEVENS R CONNORS M
Citation: Jc. Geabanacloche et al., HIV-INFECTION INDUCES PROGRESSIVE DEPLETIONS WITHIN THE CD4-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES( T), Journal of allergy and clinical immunology, 99(1), 1997, pp. 447-447
CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: POLIS MA PISCITELLI SC VOGEL S WITEBSKY FG CONVILLE PS PETTY B KOVACS JA DAVEY RT WALKER RE FALLOON J METCALF JA CRAFT C LANE HC MASUR H
Citation: Ma. Polis et al., CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1709-1714
DRUG-RESISTANCE DURING INDINAVIR THERAPY IS CAUSED BY MUTATIONS IN THE PROTEASE GENE AND IN ITS GAG SUBSTRATE CLEAVAGE SITES
Authors: ZHANG YM IMAMICHI H IMAMICHI T LANE HC FALLOON J VASUDEVACHARI MB SALZMAN NP
Citation: Ym. Zhang et al., DRUG-RESISTANCE DURING INDINAVIR THERAPY IS CAUSED BY MUTATIONS IN THE PROTEASE GENE AND IN ITS GAG SUBSTRATE CLEAVAGE SITES, Journal of virology, 71(9), 1997, pp. 6662-6670
SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS
Authors: DAVEY RT CHAITT DG PISCITELLI SC WELLS M KOVACS JA WALKER RE FALLOON J POLIS MA METCALF JA MASUR H FYFE G LANE HC
Citation: Rt. Davey et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS, The Journal of infectious diseases, 175(4), 1997, pp. 781-789
CRYSTALLURIA AND URINARY-TRACT ABNORMALITIES ASSOCIATED WITH INDINAVIR
Authors: KOPP JB MILLER KD MICAN JAM FEUERSTEIN IM VAUGHAN E BAKER C PANNELL LK FALLOON J
Citation: Jb. Kopp et al., CRYSTALLURIA AND URINARY-TRACT ABNORMALITIES ASSOCIATED WITH INDINAVIR, Annals of internal medicine, 127(2), 1997, pp. 119
A PHASE-I II PILOT-STUDY OF THE SAFETY OF THE ADOPTIVE TRANSFER OF SYNGENEIC GENE-MODIFIED CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED IDENTICAL-TWINS - CELL-GENESYS-INC PROTOCOL T-9401-BB-IND-5610/
Authors: WALKER RE BLAESE RM DAVEY RT FALLOON J MULLEN C POLIS MA FINER M MCGUIRE B ROBERTS M ZSEBO K HAVRILLA N
Citation: Re. Walker et al., A PHASE-I II PILOT-STUDY OF THE SAFETY OF THE ADOPTIVE TRANSFER OF SYNGENEIC GENE-MODIFIED CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED IDENTICAL-TWINS - CELL-GENESYS-INC PROTOCOL T-9401-BB-IND-5610/, Human gene therapy, 7(3), 1996, pp. 367-400
GENE-THERAPY FOR AIDS USING RETROVIRAL-MEDIATED GENE-TRANSFER TO DELIVER HIV-1 ANTISENSE TAR AND TRANSDOMINANT REV PROTEIN GENES TO SYNGENEIC LYMPHOCYTES IN HIV-1-INFECTED IDENTICAL-TWINS
Authors: MORGAN RA WALKER R BLAESE RM CARTER CS DAVEY RT FALLOON J KLEIN H LANE HC LEITMAN SF POLIS MA
Citation: Ra. Morgan et al., GENE-THERAPY FOR AIDS USING RETROVIRAL-MEDIATED GENE-TRANSFER TO DELIVER HIV-1 ANTISENSE TAR AND TRANSDOMINANT REV PROTEIN GENES TO SYNGENEIC LYMPHOCYTES IN HIV-1-INFECTED IDENTICAL-TWINS, Human gene therapy, 7(10), 1996, pp. 1281-1306
RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/
Authors: DAVEY RT CHAITT DG REED GF FREIMUTH WW HERPIN BR METCALF JA EASTMAN PS FALLOON J KOVACS JA POLIS MA WALKER RE MASUR H BOYLE J COLEMAN S COX SR WATHEN L DAENZER CL LANE HC
Citation: Rt. Davey et al., RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1657-1664
EMERGENCE OF PROTEASE INHIBITOR RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS AND RAPID SCREENING-PROCEDURE FOR THEIR DETECTION
Authors: VASUDEVACHARI MB ZHANG YM IMAMICHI H IMAMICHI T FALLOON J SALZMAN NP
Citation: Mb. Vasudevachari et al., EMERGENCE OF PROTEASE INHIBITOR RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS AND RAPID SCREENING-PROCEDURE FOR THEIR DETECTION, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2535-2541
CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITHTHE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: KOVACS JA VOGEL S ALBERT JM FALLOON J DAVEY RT WALKER RE POLIS MA SPOONER K METCALF JA BASELER M FYFE G LANE HC
Citation: Ja. Kovacs et al., CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITHTHE HUMAN-IMMUNODEFICIENCY-VIRUS, The New England journal of medicine, 335(18), 1996, pp. 1350-1356
INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: WALKER RE SPOONER KM KELLY G MCCLOSKEY V WOODY JN FALLOON J BASELER M PISCITELLI SC DAVEY RT POLIS MA KOVACS JA MASUR H LANE HC
Citation: Re. Walker et al., INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 174(1), 1996, pp. 63-68
COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/
Authors: KOVACS JA BECHTEL C DAVEY RT FALLOON J POLIS MA WALKER RE METCALF JA DAVEY V PISCITELLI SC BASELER M DEWAR R SALZMAN NP MASUR H LANE HC
Citation: Ja. Kovacs et al., COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/, The Journal of infectious diseases, 173(4), 1996, pp. 840-848
SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION
Authors: WALKER RE CARTER CS MUUL L NATARAJAN V HERPIN BR LEITMAN SF KLEIN HG FALLOON J DAVEY RT KOVACS JA POLIS MA MASUR H BLAESE RM LANE HC
Citation: Re. Walker et al., SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION, AIDS research and human retroviruses, 11, 1995, pp. 166-166
ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA
Authors: POLIS MA SPOONER KM BAIRD BF MANISCHEWITZ JF JAFFE HS FISHER PE FALLOON J DAVEY RT KOVACS JA WALKER RE WHITCUP SM NUSSENBLATT RB LANE HC MASUR H
Citation: Ma. Polis et al., ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA, Antimicrobial agents and chemotherapy, 39(4), 1995, pp. 882-886
INCREASES IN CD4 T-LYMPHOCYTES WITH INTERMITTENT COURSES OF INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PRELIMINARY-STUDY
Authors: KOVACS JA BASELER M DEWAR RJ VOGEL S DAVEY RT FALLOON J POLIS MA WALKER RE STEVENS R SALZMAN NP METCALF JA MASUR H LANE HC
Citation: Ja. Kovacs et al., INCREASES IN CD4 T-LYMPHOCYTES WITH INTERMITTENT COURSES OF INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PRELIMINARY-STUDY, The New England journal of medicine, 332(9), 1995, pp. 567-575
A UNIQUE SYNDROME OF IMMUNODEFICIENCY AND AUTOIMMUNITY ASSOCIATED WITH ABSENT T-CELL CD2 EXPRESSION
Authors: SNELLER MC EISENSTEIN EM BASELER M LANE HC DONOGHUE ET FALLOON J
Citation: Mc. Sneller et al., A UNIQUE SYNDROME OF IMMUNODEFICIENCY AND AUTOIMMUNITY ASSOCIATED WITH ABSENT T-CELL CD2 EXPRESSION, Journal of clinical immunology, 14(6), 1994, pp. 359-367
PHARMACOKINETICS AND SAFETY OF WEEKLY DAPSONE AND DAPSONE PLUS PYRIMETHAMINE FOR PREVENTION OF PNEUMOCYSTIS PNEUMONIA
Authors: FALLOON J LAVELLE J OGATAARAKAKI D BYRNE A GRAZIANI A MORGAN A AMANTEA MA OWNBY K POLIS M DAVEY RT KOVACS JA LANE HC MASUR H MACGREGOR RR
Citation: J. Falloon et al., PHARMACOKINETICS AND SAFETY OF WEEKLY DAPSONE AND DAPSONE PLUS PYRIMETHAMINE FOR PREVENTION OF PNEUMOCYSTIS PNEUMONIA, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1580-1587
USE OF RECOMBINANT SOLUBLE CD4 PSEUDOMONAS EXOTOXIN, A NOVEL IMMUNOTOXIN, FOR TREATMENT OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: DAVEY RT BOENNING CM HERPIN BR BATTS DH METCALF JA WATHEN L COX SR POLIS MA KOVACS JA FALLOON J WALKER RE SALZMAN N MASUR H LANE HC
Citation: Rt. Davey et al., USE OF RECOMBINANT SOLUBLE CD4 PSEUDOMONAS EXOTOXIN, A NOVEL IMMUNOTOXIN, FOR TREATMENT OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 170(5), 1994, pp. 1180-1188
Risultati: 1-25 | 26-31